ARCHIVES

FDA Updates Safety Labeling Of 5-Alpha Reductase Inhibitors

This article is from The Cancer Letter archive.

Vol. 34 No. 6 | June 24, 2011

Download PDF Visit The Full Archive

Related Articles

Advocacy: Friends To Continue Another Year

June 13, 1997

Cancer research poised for a “platinum age” as a “golden age” ends, NCI director tells AACR annual meeting.

April 29, 2005

Kadcyla Extends Median PFS In Open-Label Phase III Trial

October 25, 2013

AACI Recommends Cancer Control Guideline Changes

February 9, 1979

NIOSH To Fund 21 Projects With NCI Money

February 25, 1977

In Brief: David Johnson New ACCC President, William Dugan Named President Elect; Straus Resigns From NYMC

March 12, 1982